Novo asks FDA to bar Ozempic copies

Also: Fines for HIPAA violations max out at just $2 million. That could soon change

October 23, 2024 Check out STAT+

Sponsored By

Drew Angerer/Getty Images STAT+ | What's on the docket for Congress post-election: Chinese biotech, Medicare payments, ACA subsidies From the BIOSECURE Act to a telehealth extension to Medicare payments, key health policy issues could see breakthroughs in the lame duck session of Congress. By John Wilkerson Dietary guidelines panel stresses fruits and vegetables but stops shy of major changes  An advisory panel on dietary guidelines says American diet is flawed but more data needed to take action on ultra-processed foods or alcohol. By Elizabeth Cooney STAT+ | Q&A: Mark Cuban explains his beef with traditional PBMs — and why he thinks disruption is inevitable The billionaire best known for his past role on the TV show "Shark Tank" is seeking to disrupt the system around prescription drug sales in the U.S. By STAT Staff JOEL SAGET/AFP via Getty Images STAT+ | Novo asks FDA to bar compounders from making Ozempic copies The agency posted documents from the drugmaker requesting semaglutide be placed on the FDA's 'Demonstrable Difficulties for Compounding Lists' By Elaine Chen More state Medicaid programs consider covering GLP-1 drugs Most state Medicaid programs don't cover weight loss drugs for obesity, but that could soon change, per KFF report. By Tara Bannow STAT+ | U.K.'s cost-effectiveness agency says Alzheimer's drug donanemab does not provide good value The Eli Lilly drug will not be made available in the NHS unless the agency, NICE, finds that the medicine's benefits justify its costs. By Andrew Joseph Adobe STAT+ | Frustrated with Change Healthcare breach, senators propose removing limits on HIPAA fines Senators propose lifting the cap on fines for HIPAA data breaches. Currently such fines, imposed by HHS, are capped at about $2 million per violation. By Brittany Trang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser